Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Braunschweig
Clinical trial register · Germany

Clinical Trials in Braunschweig, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5060 matching records held by the registry are in this view. Synced 14 Oct 2026, 03:18 UTC
5060
Studies in scope
all four open statuses
2879
Recruiting now
open to new participants
987
Lead sponsors
across recruiting studies
Top sites
Berlin 1589 Hamburg 891 Essen 764 Dresden 713 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca10 Janssen Research & Development, LLC8 Stichting Hemato-Oncologie voor Volwassenen Nederland5 Boehringer Ingelheim3 University of Ulm3
Site location
Berlin1589 Hamburg891 Essen764 Dresden713 Heidelberg627
All 640 locations
Target enrolment
to

Trials with a site in Braunschweig

74 of 5060 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
AstraZeneca
Phase 3
2,800
Aachen, Bad Nenndorf, Berlin, Bonn, Brandenburg an der Havel, Braunschweig, Cloppenburg, Essen
2026-09-01
Recruiting
AstraZeneca
Phase 3
7,000
Ahrensburg, Bad Mergentheim, Bad Nenndorf, Berlin, Bonn, Brandenburg an der Havel, Braunschweig, Chemnitz
2026-08-21
Recruiting
AstraZeneca
Observational
200
Bochum, Braunschweig, Dortmund, Dresden, Hagen, Hamburg, Heilbronn, Jena
2026-06-10
Recruiting
AstraZeneca
Observational
125
Altenburg, Bad Bramstedt, Berlin, Braunschweig, Chemnitz, Erlangen, Heidelberg, Herne
2026-03-19
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
875
Aachen, Bochum, Bonn, Braunschweig, Greifswald, Halle, Hamburg, Hanover
2026-03-01
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
DrugNerandomilast
Boehringer Ingelheim
Phase 3
413
Berlin, Bonn, Braunschweig, Bremen, Cologne, Düsseldorf, Essen, Freiburg im Breisgau
2025-09-13
Recruiting
Janssen Research & Development, LLC
Phase 3
1,203
Braunschweig, Duisburg, Düsseldorf, Essen, Frankfurt am Main, Hamburg, Heidelberg, München
2025-09-02
Recruiting
AstraZeneca
Phase 3
700
Augsburg, Berlin, Braunschweig, Cologne, Dresden, Duisburg, Düsseldorf, Essen
2025-08-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt, Flensburg, Freiburg im Breisgau
2025-08-05
Active, closed
Boehringer Ingelheim
Phase 1
91
Braunschweig, Jena, Leipzig, Ulm
2025-05-14
Recruiting
Biogen
Phase 3
454
Heidelberg, Stuttgart, Villingen-Schwenningen, Frankfurt am Main, Braunschweig, Mainz, Dresden, Leipzig
2025-05-08
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt, Essen, Flensburg
2025-05-05
Recruiting
AstraZeneca
Phase 3
830
Amberg, Augsburg, by, Bad Saarow, Berlin, Bonn, Braunschweig, Essen, Flensburg
2025-04-10
Recruiting
AstraZeneca
Phase 3
840
Augsburg, Bad Saarow, Berlin, Braunschweig, Chemnitz, Düsseldorf, Erlangen, Essen
2025-03-01
Recruiting
Hannover Medical School
Not applicable
274
Berlin, Bonn, Braunschweig, Bremerhaven, Cologne, Erlangen, Essen, Halle
2025-02-19
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Aachen, Berlin, Braunschweig, Chemnitz, Dresden, Düsseldorf, Essen, Göttingen
2025-01-28
Active, closed
Daiichi Sankyo
Phase 3
700
Alzenau in Unterfranken, Berlin, Braunschweig, Dresden, Essen, Hanover, Heidelberg, Kiel
2024-11-19
Active, closed
Boehringer Ingelheim
Phase 3
11,000
Aachen, Bad Kreuznach, Bad Nenndorf, Bad Oeynhausen, Berlin, Bonn, Braunschweig, Cloppenburg
2024-08-30
Recruiting
Abbott Structural Heart Device Registry
NCT06590467Heart Diseases, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PFO - Patent Foramen Ovale
Abbott Medical Devices
Observational
2,500
München, Bremen, Jena, Braunschweig, Berlin, Bad Rothenfelde
2024-08-21
Recruiting
Fresenius Medical Care Deutschland GmbH
Not applicable
46
Aschaffenburg, Munich, Braunschweig, Paderborn, Berlin, Ulm, Würzburg
2024-07-18
Recruiting
Janssen Research & Development, LLC
Phase 3
641
Berlin, Braunschweig, Cologne, Dresden, Frankfurt am Main, Hamburg, Herne, Jena
2024-04-18
Active, closed
University of Heidelberg Medical Center
Phase 3
411
Aachen, Augsburg, Bad Saarow, Berlin, Bielefeld, Bonn, Braunschweig, Chemnitz
2024-04-05
Active, closed
AstraZeneca
Phase 3
1,898
Bergisch Gladbach, Berlin, Braunschweig, Cologne, Dresden, Duisburg, Frankfurt, Frankfurt am Main
2023-11-21
Active, closed
AstraZeneca
Phase 3
895
Berlin-Zehlendorf, Bonn, Braunschweig, Dresden, Freiburg im Breisgau, Gauting, Georgsmarienhütte, Gütersloh
2023-10-24
Recruiting
University Hospital Freiburg
Phase 3
340
Freiburg im Breisgau, Stuttgart, Aachen, Augsburg, Berlin, Bielefeld, Bochum, Braunschweig
2023-08-09
Active, closed
Bayer
Phase 3
985
Mannheim, Nürtingen, Stuttgart, Würzburg, Frankfurt am Main, Braunschweig, Göttingen, Aachen
2023-04-03
Active, closed
Sanofi
Observational
572
Aachen, Ahaus, Andernach, Berlin, Braunschweig, Buxtehude, Chemnitz, Cologne
2023-03-07
Active, closed
Registry on Percutaneous Electrochemotherapy
NCT05267080Primary Liver Cancer, Secondary Liver Cancer
Cardiovascular and Interventional Radiological Society of Europe
Observational
250
Bonn, Braunschweig, Halle, Leipzig, Regensburg
2023-01-25
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Augsburg, Bayreuth, Berlin, Bottrop, Braunschweig, Bremen, Chemnitz, Dessau
2022-12-16
Recruiting
Gilead Sciences
Phase 3
1,514
Augsburg, Berlin, Bielefeld, Bottrop, Braunschweig, Bremen, Cologne, Dortmund
2022-12-12
Active, closed
Mesh Augmented Reinforcement of Abdominal Wall Suture Line to Limit the Rate of Incisional Hernia Occurrence
NCT05424484Incisional Hernia, Incisional Hernia of Midline of Abdomen, Midline Laparotomy
Medtronic - MITG
Not applicable
123
Braunschweig, Oldenburg, Regensburg
2022-11-22
Recruiting
Pfizer
Phase 3
1,060
Freiburg im Breisgau, Tübingen, Ulm, Mainz, Aachen, Braunschweig, Chemnitz, Hamburg
2022-11-10
Recruiting
University of Ulm
Phase 3
650
Aschaffenburg, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt
2022-09-13
Recruiting
Novartis Pharmaceuticals
Phase 2
240
Munich, Ludwigshafen, Frankfurt am Main, Braunschweig, Cologne, Berlin, Mainz
2022-08-10
Recruiting
Prof. Wolfgang Janni
Phase 4
300
Aalen, Amberg, Aschaffenburg, Augsburg, Berlin, Biberach, Bonn, Braunschweig
2022-04-27
Active, closed
AstraZeneca
Phase 3
791
Berlin, Berlin-Zehlendorf, Braunschweig, Chemnitz, Cologne, Erlangen, Essen, Giessen
2022-02-18
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Berlin, Braunschweig, Cologne, Dachau, Duisburg, Halle, Hanover, Jerichow
2022-01-19
Active, closed
Gilead Sciences
Phase 3
603
Braunschweig, Esslingen am Neckar, Hamburg, Heilbronn, Immenhausen, Kassel, Lübeck, Mannheim
2021-11-17
Recruiting
Pfizer
Phase 3
893
Ulm, Würzburg, Berlin, Braunschweig, Chemnitz, München
2021-10-04
Recruiting
University Medicine Greifswald
Observational
3,000
Aachen, Berlin, Bonn, Braunschweig, Chemnitz, Cologne, Cottbus, Düsseldorf
2021-08-06
Active, closed
HistoSonics, Inc.
Not applicable
24
Braunschweig, Magdeburg
2021-06-04
Active, closed
Plasmafit® Revision Structan® Hip Endoprosthesis Cup
NCT04255966Osteolysis, Arthroplasty Complications, Instability of Prosthetic Joint, Degenerative Osteoarthritis
Aesculap AG
Observational
60
Würzburg, Braunschweig, Bonn, Homburg
2021-04-12
Recruiting
Technische Universität Dresden
Not applicable
240
Mannheim, Dresden, Ansbach, Augsburg, Berlin, Bonn, Braunschweig, Dachau
2021-01-01
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Augsburg, Braunschweig, Dresden, Duisburg, Düesseldorf, Essen, Frankfurt am Main, Hanover
2020-12-07
Active, closed
Daiichi Sankyo
Phase 3
1,600
Augsburg, Berlin, Bielefeld, Böblingen, Braunschweig, Bremen, Chemnitz, Cologne
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Immenstadt im Allgäu, Amberg, Augsburg, Bad Homburg, Berlin, Braunschweig, Chemnitz, Cologne
2020-12-02
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Berlin, Braunschweig, Dresden, Essen, München, Münster
2020-11-12
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Bad Nauheim, Leipzig, Bad Krozingen, Braunschweig, Dresden, Hamburg, Regensburg
2020-11-04
Active, closed
Bayer
Phase 3
402
Emmendingen, Freiburg im Breisgau, Mühlacker, Nürtingen, Reutlingen, Tübingen, Erlangen, Braunschweig
2020-10-20
Active, closed
Janssen Research & Development, LLC
Phase 3
696
Braunschweig, Cologne, Dresden, Duisburg, Hanover, München, Münster, Nürtingen
2020-09-23
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
DrugsVenclexta·Azacitidine·Venetoclax
Taiho Oncology, Inc.
Phase 2/3
316
Freiburg im Breisgau, Heidelberg, Braunschweig, Halle
2020-05-21
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Aschaffenburg, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt
2019-12-20
Recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
NCT04045665Atrial Fibrillation, Stroke, Bleeding
Icahn School of Medicine at Mount Sinai
Phase 3
3,200
Berlin, Göttingen, Jena, Bad Nauheim, Bad Neustadt an der Saale, Bad Oeynhausen, Bonn, Braunschweig
2019-12-13
By invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
NCT04093570Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
DrugDecitabine
Taiho Oncology, Inc.
Phase 2
332
Braunschweig, Lübeck
2019-09-30
Active, closed
University of Ulm
Phase 3
882
Aschaffenburg, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt
2019-09-04
Recruiting
University Hospital Muenster
Phase 3
683
Aachen, Augsburg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen, Chemnitz
2019-08-23
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Aachen, Braunschweig, Cologne, Eisleben Lutherstadt, Essen, Frankfurt am Main, Gronau, Hamburg
2019-06-11
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
968
Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Dortmund, Düsseldorf
2019-03-01
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Braunschweig, Duisburg, Homburg, Magdeburg, Münster, Nürtingen
2019-01-25
Active, closed
University of Heidelberg Medical Center
Phase 3
662
Aachen, Bad Saarow, Berlin, Bielefeld, Bochum, Bonn, Braunschweig, Chemnitz
2018-10-18
Recruiting
Martin Schrappe
Phase 3
5,000
Aachen, Augsburg, Berlin, Braunschweig, Chemnitz, Cologne, Cottbus, Datteln
2018-07-15
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Berlin, Braunschweig, Dresden, Düsseldorf, Erlangen, Frankfurt, Freiburg im Breisgau, Göttingen
2018-03-23
Active, closed
G7 BiSpherical Acetabular Shell PMCF Study
NCT03266874Rheumatoid Arthritis, Osteoarthritis, Noninflammatory Degenerative Joint Disease, Avascular Necrosis
Zimmer Biomet
Observational
160
Munich, Braunschweig
2017-12-10
Active, closed
University Hospital Muenster
Phase 3
650
Aachen, Augsburg, Berg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen
2017-08-03
Recruiting
Fosfomycin I.v. for Treatment of Severely Infected Patients
NCT02979951Bacterial Infections, Bone Diseases, Infectious, Osteomyelitis, Central Nervous System Bacterial Infections
Infectopharm Arzneimittel GmbH
Observational
1,000
Berlin, Braunschweig, Düsseldorf, Frankfurt, Hamburg, Jena, Kiel, Lübeck
2016-12
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Bonn, Braunschweig, Eisleben Lutherstadt, Hamburg, Hanover, Leipzig, Lübeck, Nürtingen
2015-11-27
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Braunschweig, Chemnitz, Dessau, Frankfurt, Gronau, Jena, Münster, Nürtingen
2015-11-19
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
Aachen, Berlin, Bottrop, Braunschweig, Ebersberg, Eggenfelden, Erlangen, Frankfurt
2015-08
Active, closed
Helmholtz Centre for Infection Research
Observational
782
Braunschweig, Halle
2015-03
Recruiting
International HIT-MED Registry (I-HIT-MED)
NCT02417324Childhood Brain Tumor
Universitätsklinikum Hamburg-Eppendorf
Observational
500
Aachen, Augsburg, Berlin, Bielefeld, Braunschweig, Bremen, Chemnitz, Cologne
2015-01
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 2/3
360
Aachen, Augsburg, Berlin, Bielefeld, Bonn, Braunschweig, Bremen, Chemnitz
2014-06
Active, closed
Zimmer POLAR Persona - TKA (EMEA Study)
NCT02337244Severe Knee Pain, Severe Knee Disability, Osteoarthritis, Rheumatoid Arthritis
Zimmer, GmbH
Observational
777
Braunschweig, Heidelberg
2013-11-18
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Aachen, Bergisch Gladbach, Berlin, Braunschweig, Cologne, Duisburg, Emmendingen, Frankfurt am Main
2013-10-14
Recruiting
University of Ulm
Observational
50,000
Aschaffenburg, Augsburg, Aurich, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig
2010-07-06
Rows per page Showing 1–74 of 74
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 October 2026. https://priyalifescience.com/clinical-trials-germany/city/braunschweig

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,060 studies in total at the last sync on 14 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 74 of those studies with a site in Braunschweig.

How many clinical trials are recruiting in Braunschweig?

36 of the 74 studies on this page are recruiting new participants as of the 14 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 37 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Braunschweig), 74 studies
PhaseStudiesRecruitingShare
Phase 3472063.5%
Observational13717.6%
Not applicable648.1%
Phase 2/3435.4%
Phase 2212.7%
Phase 1101.4%
Phase 4111.4%

Most active sponsors

Lead sponsors with the most studies (Braunschweig)
Lead sponsorStudiesRecruiting
AstraZeneca107
Janssen Research & Development, LLC82
Stichting Hemato-Oncologie voor Volwassenen Nederland53
Aragon Pharmaceuticals, Inc.30
Boehringer Ingelheim30
University of Ulm32
Bayer20
Daiichi Sankyo20
Gilead Sciences21
Pfizer22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.